MedPath

Prevention of Iron Deficiency in 2nd Year of Life

Phase 4
Conditions
Iron Deficiency
Anemia
Registration Number
NCT00479102
Lead Sponsor
Soroka University Medical Center
Brief Summary

Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups. Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex). Group 2 will be followed up as a control group. Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life. A follow-up blood count will be taken from all participating babies 3 months after recruitment. The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life. The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Healthy babies without iron deficiency
Exclusion Criteria
  • Babies with iron deficiency or chronic diseases, premature babies and babies with hereditary hematological disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clalit Health Services Child Health Center

🇮🇱

Rahat, Israel

© Copyright 2025. All Rights Reserved by MedPath